Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Influence of age and co-medication on dolutegravir glucuronidation in paediatric patients.
Jacobs TG, Waalewijn H, Houlden L, Bollen PDJ, Nanduudu A, Nambi E, Cassim H, Lugemwa A, Makumbi S, Monkiewicz LN, Shakeshaft C, Bamford A, Archary M, Musuro G, Chidziva E, Mujuru HA, Bwakura-Dangarembizi M, Chabala C, Turkova A, Gibb DM, Cotton MF, Aarnoutse R, Burger DM, Colbers A. Jacobs TG, et al. Among authors: archary m. Br J Clin Pharmacol. 2024 Sep 3:e16238. doi: 10.1111/bcp.16238. Online ahead of print. Br J Clin Pharmacol. 2024. PMID: 39228168
Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium.
Kuhn L, Barnabas S, Cotugno N, Peay H, Goulder P, Cotton M, Violari A, Pahwa S, Reddy K, Tagarro A, Otwombe K, Fry S, Vaz P, Lain MG, Nhampossa T, Archary M, Maiga AI, Puthanakit T, Kityo CM, Foster C, Rojo P, Klein N, Nastouli E, Tiemessen CT, de Rossi A, Ndung'u T, Persaud D, Lichterfeld M, Giaquinto C, Palma P, Rossi P; EPIICAL consortium. Kuhn L, et al. Among authors: archary m. Lancet HIV. 2024 Jul 23:S2352-3018(24)00157-7. doi: 10.1016/S2352-3018(24)00157-7. Online ahead of print. Lancet HIV. 2024. PMID: 39059402 Review.
Update: Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial.
Dzavakwa NV, Chisenga M, McHugh G, Filteau S, Gregson CL, Kasonka L, Kranzer K, Mabuda HB, Mujuru H, Redzo N, Rowland-Jones S, Schaible UE, Simms V, Ferrand RA; VITALITY team. Dzavakwa NV, et al. Trials. 2024 Jul 22;25(1):499. doi: 10.1186/s13063-024-08342-z. Trials. 2024. PMID: 39039558 Free PMC article.
Acceptability, feasibility and preliminary effectiveness of the mHealth intervention, InTSHA, on retention in care and viral suppression among adolescents with HIV in South Africa: a pilot randomized clinical trial.
Zanoni BC, Archary M, Sibaya T, Musinguzi N, Gethers CT, Goldstein M, Bergam S, Psaros C, Marconi VC, Haberer JE. Zanoni BC, et al. Among authors: archary m. AIDS Care. 2024 Jul;36(7):983-992. doi: 10.1080/09540121.2024.2361240. Epub 2024 Jul 8. AIDS Care. 2024. PMID: 38976571 Clinical Trial.
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.
Bengu N, Cromhout G, Adland E, Govender K, Herbert N, Lim N, Fillis R, Sprenger K, Vieira V, Kannie S, van Lobenstein J, Chinniah K, Kapongo C, Bhoola R, Krishna M, Mchunu N, Pascucci GR, Cotugno N, Palma P, Tagarro A, Rojo P, Roider J, Garcia-Guerrero MC, Ochsenbauer C, Groll A, Reddy K, Giaquinto C, Rossi P, Hong S, Dong K, Ansari MA, Puertas MC, Ndung'u T, Capparelli E, Lichterfeld M, Martinez-Picado J, Kappes JC, Archary M, Goulder P. Bengu N, et al. Among authors: archary m. Nat Med. 2024 Jun 6. doi: 10.1038/s41591-024-03105-4. Online ahead of print. Nat Med. 2024. PMID: 38843818
Atypical presentation of a posterior fossa tumour: A case report.
Narotam A, Archary M, Naidoo P, Naidoo Y, Naidu V. Narotam A, et al. Among authors: archary m. World J Clin Cases. 2024 May 6;12(13):2281-2285. doi: 10.12998/wjcc.v12.i13.2281. World J Clin Cases. 2024. PMID: 38808343 Free PMC article.
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years.
Turkova A, Chan MK, Kityo C, Kekitiinwa AR, Musoke P, Violari A, Variava E, Archary M, Cressey TR, Chalermpantmetagul S, Sawasdichai K, Ounchanum P, Kanjanavanit S, Srirojana S, Srirompotong U, Welch S, Bamford A, Epalza C, Fortuny C, Colbers A, Nastouli E, Walker S, Carr D, Conway M, Spyer MJ, Parkar N, White I, Nardone A, Thomason MJ, Ferrand RA, Giaquinto C, Ford D; D3 trial team. Turkova A, et al. Among authors: archary m. Contemp Clin Trials. 2024 Jul;142:107540. doi: 10.1016/j.cct.2024.107540. Epub 2024 Apr 16. Contemp Clin Trials. 2024. PMID: 38636725 Free article. Clinical Trial.
109 results